Ravi Shankar
6PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 09, 2026
Post-authorization safety study to assess the risk of diabetic ketoacidosis among type 2 diabetes mellitus patients treated with ertugliflozin compared to patients treated with other antihyperglycaemic agents in a Medicare and Medicaid population.Ashish Rai, James Marshall, Sampada Nandyala
|Mar 11, 2022
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic Hypogonadism.R Ravi Shankar, Suneri Shah, Hee-Koung Joeng
|Nov 15, 2021
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulin.Muhammad Yazid Jalaludin, Asma Deeb, Philip Zeitler
|Nov 15, 2021
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes.R Ravi Shankar, Philip Zeitler, Asma Deeb
|Sep 05, 2018
Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin.Miao Yu, R Ravi Shankar, Ruya Zhang
|Nov 16, 2017
Insulin secretory effect of sitagliptin: assessment with a hyperglycemic clamp combined with a meal challenge.Sudha S Shankar, R Ravi Shankar, Lori A Mixson
Pageof 1
Frequent Collaborators
2 joint publications
Samuel S Engel
2 joint publications
Philip Zeitler
2 joint publications
Asma Deeb
2 joint publications
Muhammad Yazid Jalaludin
2 joint publications
Ron S Newfield
1 joint publications
Barbara J Stegmann
1 joint publications
Eberhard Nieschlag
1 joint publications
Hermann M Behre
1 joint publications
Ronald S Swerdloff
1 joint publications
Ashish Rai
